As part of its ongoing mission to provide comprehensive business and financial management solutions in support of clinical trials, 

(CFS) is pleased to announce the launch of its newest offering, Site Activation Services. This  new service, which includes regulatory document collection and management as well as global investigator budget and contract management, will streamline and automate the trial activation process and minimize financial risk for clinical trial sponsors, CROs, and investigative sites.

Headed by a team dedicated to managing the complex tasks required to activate investigator sites, CFS can accelerate clinical trial cycle times by maximizing the number of sites that are activated and "enrollment ready" when the enrollment phase of the trial begins.
  

By pre-populating regulatory and financial disclosure documents with data from an enterprise-wide proprietary database, CFS ensures the accuracy of site and investigator information, prevents redundancy and speeds the time it takes to complete this paperwork. 

Through extensive audit capabilities, CFS ensures that financial disclosure information is compliant with 21CFR Part 54 and internal SOPs, consistent with Form FDA 1572 and aligned with aggregate spend payment data. 

With a global legal network operating in more than 60 countries, CFS supports complex contract negotiations around the world. 

By offering a technologically advanced project dashboard that is available 24/7, CFS offers unprecedented visibility into the status of every trial start-up document.
